Please assess the completion status of the following clinical trial:

Trial Title: Wearable Monitoring Systems for Swallowing Function and Disorders

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Inclusion criteria for healthy adults:~* Age 18-30 OR 50-90 years of age~* No history of dysphagia~* No history of a neurological disorder~* A score in the normal/mild range on the Montreal Cognitive Assessment (MoCA):~* A score of \<3 on the Eating Assessment Tool-10 (EAT-10, a self-report screening for dysphagia).~Inclusion criteria for patients with dysphagia:~* Age 18-90 years of age~* Diagnoses of dysphagia as a result of a neurological disorder (e.g., stroke, Parkinson's disease).~* A score in the normal/mild range on the Montreal Cognitive Assessment (MoCA).~* A score of ≥3 on the Eating Assessment Tool-10 (EAT-10, a self-report screening for dysphagia).~Exclusion Criteria:~• Significant cognitive impairment (a score in the moderate-severe range on MoCA):

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: t

Study Arms:
- Group A: Conventional Sensors First, Then Experimental (Tele-EaT) Sensors (Type: OTHER): Group A participants will complete the experimental protocol (swallow trials) with the conventional (commercially available) electrodes/sensors first. After a break of 10 minutes, they then will repeat the exact same experimental protocol (exact same swallow trials) with the experimental sensors (i.e., a wearable surface EMG sensors patch we are developing).
- Group B: Experimental (Tele-EaT) Sensors First, Then Conventional Sensors (Type: OTHER): Group B participants will complete the experimental protocol (swallow trials) with the experimental sensors (i.e., a wearable surface EMG sensors patch we are developing) first. After a break of 10 minutes, they then will repeat the exact same experimental protocol (exact same swallow trials) with the conventional (commercially available) electrodes/sensors.

Based on this trial design, predict the completion outcome and termination type (if applicable).